These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1445 related articles for article (PubMed ID: 12746549)

  • 1. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
    Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
    Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.
    Xiong B; Gui CS; Xu XY; Luo C; Chen J; Luo HB; Chen LL; Li GW; Sun T; Yu CY; Yue LD; Duan WH; Shen JK; Qin L; Shi TL; Li YX; Chen KX; Luo XM; Shen X; Shen JH; Jiang HL
    Acta Pharmacol Sin; 2003 Jun; 24(6):497-504. PubMed ID: 12791174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of wide-spectrum inhibitors targeting coronavirus main proteases.
    Yang H; Xie W; Xue X; Yang K; Ma J; Liang W; Zhao Q; Zhou Z; Pei D; Ziebuhr J; Hilgenfeld R; Yuen KY; Wong L; Gao G; Chen S; Chen Z; Ma D; Bartlam M; Rao Z
    PLoS Biol; 2005 Oct; 3(10):e324. PubMed ID: 16128623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease.
    Ren Z; Yan L; Zhang N; Guo Y; Yang C; Lou Z; Rao Z
    Protein Cell; 2013 Apr; 4(4):248-50. PubMed ID: 23549610
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular dynamics simulations of various coronavirus main proteinases.
    Liu HL; Lin JC; Ho Y; Hsieh WC; Chen CW; Su YC
    J Biomol Struct Dyn; 2004 Aug; 22(1):65-77. PubMed ID: 15214807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
    Lockbaum GJ; Henes M; Lee JM; Timm J; Nalivaika EA; Thompson PR; Kurt Yilmaz N; Schiffer CA
    Biochemistry; 2021 Oct; 60(39):2925-2931. PubMed ID: 34506130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
    Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro.
    Chen L; Gui C; Luo X; Yang Q; Günther S; Scandella E; Drosten C; Bai D; He X; Ludewig B; Chen J; Luo H; Yang Y; Yang Y; Zou J; Thiel V; Chen K; Shen J; Shen X; Jiang H
    J Virol; 2005 Jun; 79(11):7095-103. PubMed ID: 15890949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
    Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
    Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
    Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus 3CLpro proteinase cleavage sites: possible relevance to SARS virus pathology.
    Kiemer L; Lund O; Brunak S; Blom N
    BMC Bioinformatics; 2004 Jun; 5():72. PubMed ID: 15180906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.
    Grum-Tokars V; Ratia K; Begaye A; Baker SC; Mesecar AD
    Virus Res; 2008 Apr; 133(1):63-73. PubMed ID: 17397958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design.
    Bzówka M; Mitusińska K; Raczyńska A; Samol A; Tuszyński JA; Góra A
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32353978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site].
    Liu S; Pei J; Chen H; Zhu X; Liu Z; Ma W; He F; Lai L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 May; 35 Suppl():62-5. PubMed ID: 12914221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.
    Yang H; Yang M; Ding Y; Liu Y; Lou Z; Zhou Z; Sun L; Mo L; Ye S; Pang H; Gao GF; Anand K; Bartlam M; Hilgenfeld R; Rao Z
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13190-5. PubMed ID: 14585926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and dynamics of SARS coronavirus main proteinase (Mpro).
    Hilgenfeld R; Anand K; Mesters JR; Rao Z; Shen X; Jiang H; Tan J; Verschueren KH
    Adv Exp Med Biol; 2006; 581():585-91. PubMed ID: 17037602
    [No Abstract]   [Full Text] [Related]  

  • 18. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
    Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
    Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
    Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug design targeting the main protease, the Achilles' heel of coronaviruses.
    Yang H; Bartlam M; Rao Z
    Curr Pharm Des; 2006; 12(35):4573-90. PubMed ID: 17168763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 73.